Global Influenza Diagnostics Market Insight Report 2019 – Alere, Meridian Bioscience, QIAGEN, Roche Diagnostics, Abbott
[127 Pages Report] The influenza diagnostics market is expected to reach USD 767.4 Million by 2021 from USD 508.0 Million in 2016, at a CAGR of 8.6% from 2016 to 2021.
The report "Influenza Diagnostics Market Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 2021". The increasing prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for faster diagnosis and control of influenza are the major factors that are expected to drive the market growth in the coming years. However, variability in sensitivity and specificity among influenza diagnostic tests, presence of a complex regulatory framework for the approval of new diagnostic tests, and rising healthcare costs are expected to restrain the growth of the market to a certain extent in the coming years.
Report provides a detailed overview of the major drivers, restraints, opportunities, and threat impacting the influenza diagnostics market along with the estimates and forecasts of the revenue and market share analysis.
To know about the assumptions considered for the study, download the pdf brochure @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222985562
Scope of the Report
This research report categorizes the influenza diagnostics market into the following segments and subsegments:
By Test Type
The major players in influenza diagnostics market include Alere Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), and Abbott (U.S.).
The influenza diagnostics market is segmented on the basis of test type, end user, and region. On the basis of test type, the market is segmented into traditional diagnostic tests and molecular diagnostic tests. The traditional diagnostic tests segment is further divided into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays. The molecular diagnostic tests segment is divided into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), simple amplification-based assays (SAMBA), and other tests (microarray-based approaches and nucleic acid sequencing approaches). Among these, the traditional diagnostic tests segment is expected to account for the largest share of the global influenza diagnostics market in 2016.
Geographical Analysis
The report "Influenza Diagnostics Market Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 2021". The increasing prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for faster diagnosis and control of influenza are the major factors that are expected to drive the market growth in the coming years. However, variability in sensitivity and specificity among influenza diagnostic tests, presence of a complex regulatory framework for the approval of new diagnostic tests, and rising healthcare costs are expected to restrain the growth of the market to a certain extent in the coming years.
 |
To know about the assumptions considered for the study, download the pdf brochure @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222985562
Scope of the Report
This research report categorizes the influenza diagnostics market into the following segments and subsegments:
By Test Type
- Traditional Diagnostic Tests
- Viral Culture
- Rapid Influenza Detection Tests (RIDT)
- Direct Fluorescent Antibody (DFA) Tests
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- Nucleic Acid Sequence-based Amplification (NASBA) Tests
- Loop-mediated Isothermal Amplification-based Assays (LAMP)
- Simple Amplification-based Assays (SAMBA)
- Other Tests (Microarray-based Approaches and Nucleic Acid Sequencing Approaches)
- Hospitals & Clinics
- Reference Laboratories
- Other End Users
- North America
- Europe
- Asia-Pacific
- Rest of the World
The major players in influenza diagnostics market include Alere Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), and Abbott (U.S.).
The influenza diagnostics market is segmented on the basis of test type, end user, and region. On the basis of test type, the market is segmented into traditional diagnostic tests and molecular diagnostic tests. The traditional diagnostic tests segment is further divided into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays. The molecular diagnostic tests segment is divided into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), simple amplification-based assays (SAMBA), and other tests (microarray-based approaches and nucleic acid sequencing approaches). Among these, the traditional diagnostic tests segment is expected to account for the largest share of the global influenza diagnostics market in 2016.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the APAC influenza diagnostics market into India, China, Australia, and Rest of APAC
Company Information
To speak to our analyst for a discussion on the above findings, click @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=222985562
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
- Detailed analysis and profiling of additional market players (Up to 5)
To speak to our analyst for a discussion on the above findings, click @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=222985562
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment